Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Pemetrexed | hsa00030 | Pentose phosphate pathway | 1.03E-04 | 4 | P60891, P52209, P11413, P37837 | PRPS1, PGD, G6PD, TALDO1 | More | | Pemetrexed | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Pemetrexed | hsa00071 | Fatty acid degradation | 3.50E-02 | 4 | O75521, P00325, P11766, P33121 | ECI2, ADH1B, ADH5, ACSL1 | More | | Pemetrexed | hsa00230 | Purine metabolism | 4.02E-02 | 2 | P31350, P21589 | RRM2, NT5E | More | | Pemetrexed | hsa00240 | Pyrimidine metabolism | 2.54E-04 | 3 | P31350, P21589, P04818 | RRM2, NT5E, TYMS | More | | Pemetrexed | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Pemetrexed | hsa00480 | Glutathione metabolism | 1.35E-02 | 1 | P11413 | G6PD | More | | Pemetrexed | hsa00500 | Starch and sucrose metabolism | 1.54E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Pemetrexed | hsa00512 | Mucin type O-glycan biosynthesis | 4.86E-02 | 2 | O95395, Q9NY28 | GCNT3, GALNT8 | More | | Pemetrexed | hsa00531 | Glycosaminoglycan degradation | 4.51E-02 | 2 | P22304, P06865 | IDS, HEXA | More | | Pemetrexed | hsa00600 | Sphingolipid metabolism | 4.56E-02 | 3 | Q9BX95, Q06136, P06280 | SGPP1, FVT1, GLA | More | | Pemetrexed | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.62E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Pemetrexed | hsa00670 | One carbon pool by folate | 3.62E-02 | 1 | P00374 | DHFR | More | | Pemetrexed | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Pemetrexed | hsa00790 | Folate biosynthesis | 3.62E-02 | 1 | P00374 | DHFR | More | | Pemetrexed | hsa00830 | Retinol metabolism | 2.20E-02 | 4 | P00325, P11766, Q9BPW9, O75911 | ADH1B, ADH5, DHRS9, DHRS3 | More | | Pemetrexed | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Pemetrexed | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Pemetrexed | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Pemetrexed | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Pemetrexed | hsa01523 | Antifolate resistance | 6.06E-03 | 2 | Q92820, P04818 | GGH, TYMS | More | | Pemetrexed | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Pemetrexed | hsa03010 | Ribosome | 1.53E-05 | 8 | P62753, P62906, P46776, Q07020, P61513, P27635, P62249, P23396 | RPS6, RPL10A, RPL27A, RPL18, RPL37A, RPL10, RPS16, RPS3 | More | | Pemetrexed | hsa03013 | RNA transport | 7.33E-06 | 12 | O14980, P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, EIF4A2, EIF4B, TACC3 | More | | Pemetrexed | hsa03040 | Spliceosome | 4.48E-04 | 10 | Q14562, O43143, O60508, P17844, P51991, P61978, Q07955, Q01130, Q13243, P11142 | DHX8, DHX15, CDC40, DDX5, HNRPA3, HNRPK, SFRS1, SFRS2, SFRS5, HSPA8 | More | | Pemetrexed | hsa03060 | Protein export | 2.43E-02 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Pemetrexed | hsa04014 | Ras signaling pathway | 8.66E-03 | 7 | Q9NRA1, Q13009, P0DP23, P62873, P63218, P50151, P19174 | PDGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Pemetrexed | hsa04015 | Rap1 signaling pathway | 2.26E-02 | 3 | P25116, Q8TEU7, P08514 | F2R, RAPGEF6, ITGA2B | More | | Pemetrexed | hsa04022 | cGMP-PKG signaling pathway | 1.05E-02 | 3 | P24844, Q8WYR1, Q15746 | MYL9, PIK3R5, MYLK | More | | Pemetrexed | hsa04024 | cAMP signaling pathway | 1.40E-02 | 3 | P48058, P25116, P24844 | GRIA4, F2R, MYL9 | More | | Pemetrexed | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 5.82E-03 | 8 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, P14784, P09603 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL2RB, CSF1 | More | | Pemetrexed | hsa04062 | Chemokine signaling pathway | 7.46E-06 | 18 | P25024, P25025, P09341, P19875, P47992, Q9UBD3, P07948, P42338, P19174, P62873, P63218, P50151, Q08881, Q13009, P14598, P42224, P25963, P49841 | CXCR1, CXCR2, CXCL1, CXCL2, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, ITK, TIAM1, NCF1, STAT1, NFKBIA, GSK3B | More | | Pemetrexed | hsa04064 | NF-kappa B signaling pathway | 7.38E-05 | 19 | P10415, Q13489, O00463, Q13546, P14778, P01584, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q8WV28, P24522, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, TRAF5, RIPK1, IL1R1, IL1B, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, BLNK, GADD45A, CXCL1, CXCL2, LTB, CYLD | More | | Pemetrexed | hsa04070 | Phosphatidylinositol signaling system | 2.93E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Pemetrexed | hsa04071 | Sphingolipid signaling pathway | 5.28E-05 | 9 | P21453, Q9H228, P01375, Q13362, Q16537, Q9BX95, Q16539, P10415, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, PPP2R5E, SGPP1, MAPK14, BCL2, GAB2 | More | | Pemetrexed | hsa04072 | Phospholipase D signaling pathway | 5.05E-03 | 9 | P42338, Q9UQC2, P43657, P25024, P25025, P19174, Q8WYR1, Q15438, P51828 | PIK3CB, GAB2, P2RY5, CXCR1, CXCR2, PLCG1, PIK3R5, PSCD1, ADCY7 | More | | Pemetrexed | hsa04110 | Cell cycle | 2.34E-02 | 3 | P06493, O60566, P33981 | CDK1, BUB1B, TTK | More | | Pemetrexed | hsa04115 | p53 signaling pathway | 3.34E-02 | 2 | P31350, P06493 | RRM2, CDK1 | More | | Pemetrexed | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Pemetrexed | hsa04140 | Autophagy - animal | 3.72E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Pemetrexed | hsa04141 | Protein processing in endoplasmic reticulum | 3.12E-05 | 13 | P18848, P30101, Q15437, Q15436, P60604, Q99941, P11142, P07900, P08238, Q9NR31, P14625, Q9H173, Q9UNL2 | ATF4, PDIA3, SEC23B, SEC23A, UBE2G2, CREBL1, HSPA8, HSP90AA1, HSP90AB1, SAR1A, HSP90B1, SIL1, SSR3 | More | | Pemetrexed | hsa04142 | Lysosome | 3.32E-03 | 6 | P06865, P22304, Q13510, P07602, P61916, Q04900 | HEXA, IDS, ASAH1, PSAP, NPC2, CD164 | More | | Pemetrexed | hsa04145 | Phagosome | 6.51E-03 | 6 | P11215, P14598, Q71U36, Q13509, P68371, Q13488 | ITGAM, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1 | More | | Pemetrexed | hsa04151 | PI3K-Akt signaling pathway | 4.12E-04 | 9 | P62753, P27348, P07900, P14625, Q16363, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, HSP90B1, LAMA4, TNXB, CREBL1, ATF4, SGK | More | | Pemetrexed | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Pemetrexed | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Pemetrexed | hsa04213 | Longevity regulating pathway - multiple species | 3.10E-03 | 6 | P42338, Q9Y4H2, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IRS2, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Pemetrexed | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.65E-04 | 8 | P67936, P51828, Q8WYR1, Q99941, P18848, Q13362, P0DP24, Q13557 | TPM4, ADCY7, PIK3R5, CREBL1, ATF4, PPP2R5C, CALM2, CAMK2D | More | | Pemetrexed | hsa04270 | Vascular smooth muscle contraction | 1.75E-03 | 6 | Q15746, P24844, P0DP24, P51828, P35579, P35749 | MYLK, MYL9, CALM2, ADCY7, MYH9, MYH11 | More | | Pemetrexed | hsa04330 | Notch signaling pathway | 2.93E-02 | 3 | Q13547, Q92769, Q92830 | HDAC1, HDAC2, KAT2A | More | | Pemetrexed | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Pemetrexed | hsa04371 | Apelin signaling pathway | 7.95E-04 | 7 | P62873, P63218, P50151, Q13370, Q14344, P84022, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD3, CALM1 | More | | Pemetrexed | hsa04380 | Osteoclast differentiation | 2.05E-03 | 12 | Q9NQC7, Q9UQC2, Q16539, P23458, P06239, P01584, P14778, O75015, Q8WV28, P01375, Q15080, P78324 | CYLD, GAB2, MAPK14, JAK1, LCK, IL1B, IL1R1, FCGR3B, BLNK, TNF, NCF4, SIRPA | More | | Pemetrexed | hsa04510 | Focal adhesion | 3.36E-02 | 3 | P08514, Q15746, P24844 | ITGA2B, MYLK, MYL9 | More | | Pemetrexed | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Pemetrexed | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Pemetrexed | hsa04530 | Tight junction | 7.42E-04 | 4 | Q8TEU7, O00501, Q14247, P24844 | RAPGEF6, CLDN5, CTTN, MYL9 | More | | Pemetrexed | hsa04540 | Gap junction | 1.08E-02 | 4 | Q13509, P68371, Q71U36, Q9NRA1 | TUBB3, TUBB2C, TUBA1A, PDGFC | More | | Pemetrexed | hsa04610 | Complement and coagulation cascades | 2.94E-02 | 2 | P25116, P10909 | F2R, CLU | More | | Pemetrexed | hsa04611 | Platelet activation | 1.59E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Pemetrexed | hsa04612 | Antigen processing and presentation | 3.74E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Pemetrexed | hsa04613 | Neutrophil extracellular trap formation | 9.38E-05 | 17 | O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P0C0S5, Q6FI13, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AFZ, H2AC18; H2AC19, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Pemetrexed | hsa04614 | Renin-angiotensin system | 2.74E-02 | 3 | P15144, P08311, O75787 | ANPEP, CTSG, ATP6AP2 | More | | Pemetrexed | hsa04621 | NOD-like receptor signaling pathway | 2.24E-03 | 15 | Q16539, Q14643, P21796, P10599, Q9H1Y0, P43490, O00463, P29728, Q05823, P01375, P09341, P49913, P59665, P59666, P12838 | MAPK14, ITPR1, VDAC1, TXN, ATG5, PBEF1, TRAF5, OAS2, RNASEL, TNF, CXCL1, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Pemetrexed | hsa04623 | Cytosolic DNA-sensing pathway | 2.59E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Pemetrexed | hsa04625 | C-type lectin receptor signaling pathway | 8.11E-03 | 9 | Q9ULY5, P01584, Q9NQC7, P20749, Q14643, P01375, Q13191, P0DP24, Q16539 | CLEC4E, IL1B, CYLD, BCL3, ITPR1, TNF, CBLB, CALM2, MAPK14 | More | | Pemetrexed | hsa04640 | Hematopoietic cell lineage | 8.88E-06 | 15 | P13612, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P09564, P13765, P01375, P09603, P01584 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF, CSF1, IL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P41440 | SLC19A1 | Reduced folate transporter | P13612 | ITGA4 | Integrin alpha-4 | -0.886 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P13612 | ITGA4 | Integrin alpha-4 | -0.74 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13612 | ITGA4 | Integrin alpha-4 | -0.797 | P41440 | SLC19A1 | Reduced folate transporter | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.783 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P41440 | SLC19A1 | Reduced folate transporter | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.819 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.721 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | Q13547 | HDAC1 | Histone deacetylase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.837 | Q13547 | HDAC1 | Histone deacetylase 1 | P11215 | ITGAM | Integrin alpha-M | -0.751 | P41440 | SLC19A1 | Reduced folate transporter | P15144 | ANPEP | Aminopeptidase N | 0.706 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P15144 | ANPEP | Aminopeptidase N | 0.76 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P15144 | ANPEP | Aminopeptidase N | 0.851 | P41440 | SLC19A1 | Reduced folate transporter | P11836 | MS4A1 | B-lymphocyte antigen CD20 | -0.777 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P11836 | MS4A1 | B-lymphocyte antigen CD20 | -0.71 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P25063 | CD24 | Signal transducer CD24 | 0.866 | Q13547 | HDAC1 | Histone deacetylase 1 | P25063 | CD24 | Signal transducer CD24 | -0.706 | P41440 | SLC19A1 | Reduced folate transporter | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P41440 | SLC19A1 | Reduced folate transporter | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.811 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.793 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P41440 | SLC19A1 | Reduced folate transporter | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.72 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.839 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.781 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | Q13547 | HDAC1 | Histone deacetylase 1 | P09564 | CD7 | T-cell antigen CD7 | 0.738 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.757 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P01375 | TNF | Tumor necrosis factor | 0.788 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P41440 | SLC19A1 | Reduced folate transporter | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | 0.705 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 |
| Pemetrexed | hsa04650 | Natural killer cell mediated cytotoxicity | 1.32E-06 | 13 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P01375 | TNF | Tumor necrosis factor | P01375 | TNF | Tumor necrosis factor | 1 | P41440 | SLC19A1 | Reduced folate transporter | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.904 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.761 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P41440 | SLC19A1 | Reduced folate transporter | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.706 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P01375 | TNF | Tumor necrosis factor | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.717 | P41440 | SLC19A1 | Reduced folate transporter | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.773 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P01375 | TNF | Tumor necrosis factor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.727 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P41440 | SLC19A1 | Reduced folate transporter | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.792 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.82 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P01375 | TNF | Tumor necrosis factor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.769 | P41440 | SLC19A1 | Reduced folate transporter | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.87 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.91 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P01375 | TNF | Tumor necrosis factor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.754 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P41440 | SLC19A1 | Reduced folate transporter | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.76 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | P01375 | TNF | Tumor necrosis factor | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.838 | P41440 | SLC19A1 | Reduced folate transporter | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.736 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.846 | P01375 | TNF | Tumor necrosis factor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.814 | P41440 | SLC19A1 | Reduced folate transporter | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.736 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.846 | P01375 | TNF | Tumor necrosis factor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.814 |
| Pemetrexed | hsa04657 | IL-17 signaling pathway | 3.31E-03 | 8 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Pemetrexed | hsa04658 | Th1 and Th2 cell differentiation | 5.37E-08 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, P23458, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, JAK1, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P41440 | SLC19A1 | Reduced folate transporter | Q04759 | PRKCQ | Protein kinase C theta type | -0.747 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q04759 | PRKCQ | Protein kinase C theta type | -0.91 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P41440 | SLC19A1 | Reduced folate transporter | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P41440 | SLC19A1 | Reduced folate transporter | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.773 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.828 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P41440 | SLC19A1 | Reduced folate transporter | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.811 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.793 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P41440 | SLC19A1 | Reduced folate transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.8 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.777 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.905 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | P41440 | SLC19A1 | Reduced folate transporter | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.876 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.788 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.757 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | P41440 | SLC19A1 | Reduced folate transporter | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.733 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 |
| Pemetrexed | hsa04659 | Th17 cell differentiation | 6.17E-07 | 18 | P25963, Q04759, Q16539, P19174, P06239, P42224, P14784, P13765, P14778, Q9UL17, P23771, P84022, P01584, P08238, P07766, P09693, P20963, P23458 | NFKBIA, PRKCQ, MAPK14, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, IL1B, HSP90AB1, CD3E, CD3G, CD247, JAK1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P41440 | SLC19A1 | Reduced folate transporter | Q04759 | PRKCQ | Protein kinase C theta type | -0.747 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P41440 | SLC19A1 | Reduced folate transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.8 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.717 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P41440 | SLC19A1 | Reduced folate transporter | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.783 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P41440 | SLC19A1 | Reduced folate transporter | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.876 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | P41440 | SLC19A1 | Reduced folate transporter | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P41440 | SLC19A1 | Reduced folate transporter | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.811 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P41440 | SLC19A1 | Reduced folate transporter | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.773 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 |
| Pemetrexed | hsa04660 | T cell receptor signaling pathway | 1.72E-08 | 16 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P01375 | TNF | Tumor necrosis factor | 0.788 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.779 | P41440 | SLC19A1 | Reduced folate transporter | Q04759 | PRKCQ | Protein kinase C theta type | -0.747 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q04759 | PRKCQ | Protein kinase C theta type | -0.91 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.735 | P41440 | SLC19A1 | Reduced folate transporter | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.817 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.799 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.852 | P41440 | SLC19A1 | Reduced folate transporter | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.745 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P41440 | SLC19A1 | Reduced folate transporter | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P41440 | SLC19A1 | Reduced folate transporter | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.773 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.828 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P41440 | SLC19A1 | Reduced folate transporter | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.811 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.793 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P41440 | SLC19A1 | Reduced folate transporter | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.72 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.839 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.781 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P41440 | SLC19A1 | Reduced folate transporter | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.851 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.796 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P41440 | SLC19A1 | Reduced folate transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.8 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P41440 | SLC19A1 | Reduced folate transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.747 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 |
| Pemetrexed | hsa04664 | Fc epsilon RI signaling pathway | 4.48E-04 | 5 | P04141, P07948, P19174, P09917, P20292 | CSF2, LYN, PLCG1, ALOX5, ALOX5AP | More | | Pemetrexed | hsa04668 | TNF signaling pathway | 4.96E-02 | 6 | O00463, Q13546, Q13489, Q16539, Q13077, P14780 | TRAF5, RIPK1, BIRC3, MAPK14, TRAF1, MMP9 | More | | Pemetrexed | hsa04672 | Intestinal immune network for IgA production | 1.66E-02 | 3 | P10747, P13765, P13612 | CD28, HLA-DOB, ITGA4 | More | | Pemetrexed | hsa04713 | Circadian entrainment | 2.18E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Pemetrexed | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Pemetrexed | hsa04724 | Glutamatergic synapse | 1.48E-03 | 6 | P48058, P62873, P63218, P50151, P15104, Q9NSB8 | GRIA4, GNB1, GNG5, GNG10, GLUL, HOMER2 | More | | Pemetrexed | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Pemetrexed | hsa04726 | Serotonergic synapse | 3.80E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Pemetrexed | hsa04727 | GABAergic synapse | 4.18E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Pemetrexed | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Pemetrexed | hsa04730 | Long-term depression | 4.86E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Pemetrexed | hsa04744 | Phototransduction | 9.21E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Pemetrexed | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.14E-04 | 11 | P14778, P01584, P51828, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759, P0DP24 | IL1R1, IL1B, ADCY7, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ, CALM2 | More | | Pemetrexed | hsa04810 | Regulation of actin cytoskeleton | 1.38E-03 | 4 | P24844, Q15746, P08514, P25116 | MYL9, MYLK, ITGA2B, F2R | More | | Pemetrexed | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Pemetrexed | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Pemetrexed | hsa04912 | GnRH signaling pathway | 6.39E-03 | 8 | P51828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P0DP24, P22694 | ADCY7, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, CALM2, PRKACB | More | | Pemetrexed | hsa04915 | Estrogen signaling pathway | 1.02E-04 | 8 | Q99941, P18848, P51828, P07900, P0DMV8, P11142, P0DP24, Q15788 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA1A, HSPA8, CALM2, NCOA1 | More | | Pemetrexed | hsa04918 | Thyroid hormone synthesis | 1.98E-04 | 5 | P51828, Q99941, P18848, P14625, P02768 | ADCY7, CREBL1, ATF4, HSP90B1, ALB | More | | Pemetrexed | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Pemetrexed | hsa04921 | Oxytocin signaling pathway | 6.00E-04 | 6 | Q15746, P0DP24, P51828, P24844, Q96RR4, Q8WYR1 | MYLK, CALM2, ADCY7, MYL9, CAMKK2, PIK3R5 | More | | Pemetrexed | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Pemetrexed | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Pemetrexed | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Pemetrexed | hsa04926 | Relaxin signaling pathway | 3.34E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Pemetrexed | hsa04927 | Cortisol synthesis and secretion | 6.33E-04 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Pemetrexed | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Pemetrexed | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Pemetrexed | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Pemetrexed | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Pemetrexed | hsa04940 | Type I diabetes mellitus | 3.64E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Pemetrexed | hsa04962 | Vasopressin-regulated water reabsorption | 2.18E-02 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Pemetrexed | hsa04970 | Salivary secretion | 4.92E-02 | 4 | P07550, P22694, Q14643, P49913 | ADRB2, PRKACB, ITPR1, CAMP | More | | Pemetrexed | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Pemetrexed | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Pemetrexed | hsa05012 | Parkinson disease | 1.77E-02 | 6 | P60604, P19174, P0DP23, Q71U36, Q13509, P68371 | UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3, TUBB2C | More | | Pemetrexed | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Pemetrexed | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Pemetrexed | hsa05032 | Morphine addiction | 2.18E-02 | 4 | P62873, P63218, P50151, Q13370 | GNB1, GNG5, GNG10, PDE3B | More | | Pemetrexed | hsa05034 | Alcoholism | 2.79E-02 | 2 | P62879, Q9BTM1 | GNB2, H2AFJ | More | | Pemetrexed | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.93E-06 | 9 | Q16539, P25963, Q13488, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, NFKBIA, TCIRG1, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Pemetrexed | hsa05130 | Pathogenic Escherichia coli infection | 3.29E-03 | 9 | Q71U36, Q14247, O00501, P16333, Q13509, P68371, P25116, Q14344, P25963 | TUBA1A, CTTN, CLDN5, NCK1, TUBB3, TUBB2C, F2R, GNA13, NFKBIA | More | | Pemetrexed | hsa05132 | Salmonella infection | 2.75E-02 | 7 | P25963, P08238, O75369, Q71U36, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, FLNB, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Pemetrexed | hsa05134 | Legionellosis | 1.49E-03 | 5 | P25963, P11215, P11142, P09341, P19875 | NFKBIA, ITGAM, HSPA8, CXCL1, CXCL2 | More | | Pemetrexed | hsa05140 | Leishmaniasis | 3.10E-03 | 13 | P13612, O75015, P14598, P11215, P23458, P42224, P13765, O60603, P25963, P01375, P01584, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, ITGAM, JAK1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, IL1B, MAPK14, NCF4 | More | | Pemetrexed | hsa05144 | Malaria | 2.71E-04 | 6 | P60033, O60603, P01375, P35443, P01584, P26718 | CD81, TLR2, TNF, THBS4, IL1B, KLRK1 | More | | Pemetrexed | hsa05145 | Toxoplasmosis | 3.55E-02 | 3 | P23458, Q8WYR1, P0DMV8 | JAK1, PIK3R5, HSPA1A | More | | Pemetrexed | hsa05146 | Amoebiasis | 8.07E-06 | 13 | P01584, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | IL1B, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Pemetrexed | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Pemetrexed | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Pemetrexed | hsa05163 | Human cytomegalovirus infection | 1.79E-04 | 14 | P25963, P62873, P63218, P50151, Q14643, P0DP23, Q14344, P49841, P14778, P25025, Q16539, O00463, P30101, P01568 | NFKBIA, GNB1, GNG5, GNG10, ITPR1, CALM1, GNA13, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5, PDIA3, IFNA21 | More | | Pemetrexed | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.85E-05 | 15 | P01568, P42224, P25963, P49841, P62873, P63218, P50151, P09341, P19174, Q14643, O15123, P07948, Q16539, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, GSK3B, GNB1, GNG5, GNG10, CXCL1, PLCG1, ITPR1, ANGPT2, LYN, MAPK14, CSF2, CALM1 | More | | Pemetrexed | hsa05168 | Herpes simplex virus 1 infection | 3.79E-02 | 9 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, ZNF211, ZNF189 | More | | Pemetrexed | hsa05169 | Epstein-Barr virus infection | 1.24E-03 | 13 | Q13547, Q92769, O00463, Q16539, P07948, P30101, Q13761, P24522, P30279, P29728, P07766, P09693, P20963 | HDAC1, HDAC2, TRAF5, MAPK14, LYN, PDIA3, RUNX3, GADD45A, CCND2, OAS2, CD3E, CD3G, CD247 | More | | Pemetrexed | hsa05170 | Human immunodeficiency virus 1 infection | 1.19E-02 | 8 | P62873, P63218, P50151, P0DP23, P30101, P01568, P25963, P19174 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, NFKBIA, PLCG1 | More | | Pemetrexed | hsa05171 | Coronavirus disease - COVID-19 | 4.36E-05 | 8 | P23396, P62753, P62249, P62906, P27635, Q07020, P46776, P61513 | RPS3, RPS6, RPS16, RPL10A, RPL10, RPL18, RPL27A, RPL37A | More | | Pemetrexed | hsa05200 | Pathways in cancer | 2.14E-04 | 17 | P17301, P08238, P42224, P25963, P19174, P43246, P84022, P20585, P62873, P62879, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | ITGA2, HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, MSH3, GNB1, GNB2, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Pemetrexed | hsa05202 | Transcriptional misregulation in cancer | 7.36E-06 | 19 | Q15532, P41732, P17844, P14780, P27930, Q15744, Q16548, Q13489, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | SS18, TSPAN7, DDX5, MMP9, IL1R2, CEBPE, BCL2A1, BIRC3, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09958 | FURIN | Furin | Q15532 | SS18 | Protein SSXT | -0.749 | P09958 | FURIN | Furin | P41732 | TSPAN7 | Tetraspanin-7 | 0.719 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.863 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.9 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.94 | P09958 | FURIN | Furin | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.843 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.721 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | P09958 | FURIN | Furin | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.763 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.772 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.776 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.958 | P09958 | FURIN | Furin | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.793 | P09958 | FURIN | Furin | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.714 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.796 | P09958 | FURIN | Furin | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.741 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.716 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P09958 | FURIN | Furin | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.742 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.716 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P09958 | FURIN | Furin | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.742 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P05164 | MPO | Myeloperoxidase | 0.909 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05164 | MPO | Myeloperoxidase | 0.719 | P09958 | FURIN | Furin | P05164 | MPO | Myeloperoxidase | 0.708 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.882 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.784 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P08246 | ELA2 | Neutrophil elastase | 0.889 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08246 | ELA2 | Neutrophil elastase | 0.702 | P09958 | FURIN | Furin | P08246 | ELA2 | Neutrophil elastase | 0.757 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.85 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.783 | P09958 | FURIN | Furin | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.811 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.919 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q92769 | HDAC2 | Histone deacetylase 2 | -0.7 | P09958 | FURIN | Furin | Q92769 | HDAC2 | Histone deacetylase 2 | -0.798 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P12980 | LYL1 | Protein lyl-1 | 0.702 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12980 | LYL1 | Protein lyl-1 | 0.784 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.859 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | P09958 | FURIN | Furin | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.806 |
| Pemetrexed | hsa05203 | Viral carcinogenesis | 1.46E-02 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | | Pemetrexed | hsa05212 | Pancreatic cancer | 4.75E-02 | 3 | P42224, P84022, O75293 | STAT1, SMAD3, GADD45B | More | | Pemetrexed | hsa05214 | Glioma | 4.75E-02 | 3 | P0DP23, P19174, O75293 | CALM1, PLCG1, GADD45B | More | | Pemetrexed | hsa05215 | Prostate cancer | 4.48E-02 | 2 | P18848, P14625 | ATF4, HSP90B1 | More | | Pemetrexed | hsa05217 | Basal cell carcinoma | 1.72E-03 | 5 | Q13635, P04628, P49841, Q9UJU2, P24522 | PTCH1, WNT1, GSK3B, LEF1, GADD45A | More | | Pemetrexed | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | | Pemetrexed | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.76E-04 | 11 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, P23458, O60603, Q04759, Q16539 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, JAK1, TLR2, PRKCQ, MAPK14 | More | | Pemetrexed | hsa05310 | Asthma | 1.66E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Pemetrexed | hsa05321 | Inflammatory bowel disease | 7.58E-05 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, P01584 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL1B | More | | Pemetrexed | hsa05323 | Rheumatoid arthritis | 1.58E-02 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Pemetrexed | hsa05332 | Graft-versus-host disease | 2.03E-03 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Pemetrexed | hsa05415 | Diabetic cardiomyopathy | 3.59E-02 | 1 | P11413 | G6PD | More | | |